frc-logo
  • HOME
  • TOP PICKS
    frc-logo
    • Policies
    • Privacy Policy
    • Terms of Service
    • Company
    • About Us
    • Our Team
    • Resources
    • Videos
    • Research Reports

    * FRC provides issuer paid research on some of the companies mentioned on this website. **past performance should not be taken as any indication of future returns.

    © 2025 Fundamental Research . All Rights Reserved.

    Home
    Research
    Screener
    Top Picks
    Home🔹Analysts' Ideas🔹Promising Drill Results, Sleep Gummy Launch, and Biotech Advancements
    Analysts' Ideas of the Week

    Promising Drill Results, Sleep Gummy Launch, and Biotech Advancements

    Published: 3/17/2025

    Author: FRC Analysts

    Main image for Promising Drill Results, Sleep Gummy Launch, and Biotech Advancements
    *This article and research coverage is paid for and commissioned by issuers. See the bottom of this article for other important disclosures, rating, and risk definitions.

    In this edition, we analyze the performance of our top picks, including a potash junior, whose shares rose 42% last week. Additionally, we highlight key updates from other resource companies, as well as biotech and healthcare companies under our coverage.

    Highlights: 

    • Gain insights into companies under coverage that experienced significant developments last week, along with our analysts' commentary and actionable takeaways.
    • FRC top picks and standout performers from the past week

    Updates on Resource Companies Under Coverage

    Aton Resources Inc. (ANLBF, AAN.V)

    PR Title: Reports further results from the Abu Marawat diamond drilling program (Egypt)

    Analyst Opinion: Positive – Twenty six out of the 31 drillholes, located along the southern and eastern margins of the current resource estimate, returned significant high-grade polymetallic intercepts, including 27.6 m of 4.15 g/t AuEq, 16.9 m of 5.29 g/t, and 3.8 m of 8.15 g/t. Aton is advancing multiple gold projects in Egypt, with NI 43-101 compliant resources totaling 0.83 Moz AuEq across two projects.

    Grid Metals Corp. (GRDM.V, MSMGF)

    PR Title: Cesium project updates (Manitoba)

    Analyst Opinion: Positive – Initial results from a cesium exploration drill program at the Donner lithium-cesium project have confirmed that a high-grade dyke extends for at least 150 m along strike, and over 100 m at depth. The company is awaiting assay results. GRDM is planning a cesium exploration program at its Falcon West lithium-cesium project as well. Cesium, classified as a critical mineral by both the U.S. and Canada, is vital for high-temperature drilling fluids, with numerous high-tech and industrial applications.

    Silver Dollar Resources Inc. (SLVDF, SLV.CN)

    PR Title: Drill results from the Ranger-Page project (Idaho)

    Analyst Opinion: Positive – A recently completed drill program at two geophysical targets confirmed near-surface mineralization, with bonanza grades of up to 17.4 opt AgEq, and 18.7 opt. This drill-ready project hosts six historic mines, which have produced over 1.1 Blbs of zinc and lead, and 14.6 Moz of silver.

    Updates on Financials, Technology, Energy, and Special Situations Companies Under Coverage

    Delivra Health Brands Inc./ TSXV: DHB

    PR Title: Launches a six-count sleep gummies product into the Canadian market

    FRC Opinion: Positive - This product launch (primarily targeting travelers) builds on the positive reception of DHB's 60-count Dream Water® Gummies, launched in Canada in 2024. The new product will be available nationwide through established retail and e-commerce partners. We note that the 60-count product has received favorable reviews, and strong ratings, on Amazon (NASDAQ: AMZN).

    Q2-FY2025 (ended December 2024) revenue was up 34% YoY. We believe FY2025 revenue will be driven by organic growth and new products like Dream Water Sleep Gummies and Dream Water Immunity Shots, supported by increasing awareness of sleep’s role in physical and mental health. DHB is trading at just 0.25x revenue, while comparable Personal Care companies trade at 1.20x on average, a 79% discount.

     


     

    NurExone Biologic Inc./TSXV: NRX

    PR Title: Positive preclinical studies

    Positive - NRX has completed another preclinical study to support its application for an Investigational New Drug (IND) designation, a necessary step before initiating human clinical trials, for its ExoPTEN treatment for acute spinal cord injury (SCI). ExoPTEN has received orphan drug designation from the U.S. FDA, and the European Medicines Agency (EMA). The latest study showed that ExoPTEN treatment improved motor function and blood flow at the injury site, crucial for tissue healing and recovery. We note that there is currently no cure for SCI.

     


     

    FRC Top Picks

    The following table shows last week’s top five performers among our Top Picks. The top performer, Millennial Potash Corp. (TSXV: MLP), was up 42%. MLP is advancing a potash project in Gabon.  

    Top Five Weekly Performers WoW Returns
    Millennial Potash Corp. (MLP.V) 42%
    World Copper Ltd. (WCU.V) 38%
    Southern Silver Exploration Corp. (SSV.V) 29%
    Contango Ore Inc. (CTGO) 18.90%
    Hot Chili Limited (HHLKF) 17.30%

    * Past performance is not indicative of future performance (as of Mar 17, 2025)

     

    RC's Top Picks Portfolio vs TSXV Total Returns

     

    Performance by Sector 

    Total Return 1 Week 1 mo 3 mo 6 mo 1 yr 3 yr Since launch
    Mining 14.10% 10.70% 16.00% 11.20% 14.90% -47.60% -6.00%
    Cannabis N/A N/A N/A N/A N/A -43.70% -23.60%
    Tech 7.40% 21.70% 48.70% 49.40% 15.80% -15.40% -6.20%
    Special Situations (MIC) -1.70% -15.60% 7.00% 1.70% 34.90% -46.80% 1.50%
    Private Companies N/A N/A N/A N/A 6.70% 20.50% 30.50%
    Portfolio (Total) 11.00% 6.50% 16.20% 11.20% 16.70% -28.80% 3.10%
    Benchmark (Total) 5.30% -2.60% 4.90% 7.50% 14.00% -26.60% -29.30%
    Portfolio (Annualized) - - - - 16.70% -10.70% 0.30%
    Benchmark (Annualized) - - - - 14.00% -9.80% -3.00%

    1. Since the earliest initiating date of companies in the list of Top Picks  (as of Mar 17, 2025)

    2. Green (blue) indicates FRC's picks outperformed (underperformed) the benchmark.

    3. Past performance is not indicative of future performance.

    Latest Research Reports
    Capital Direct I Income Trust 🔹 Mortgage
    Record Receivables and Earnings with Reduced Risk ProfilePublished on:5/8/2025
    Thumbnail for Record Receivables and Earnings with Reduced Risk Profile
    Trident Resources Corp. 🔹 Other Industrial Metals & Mining
    A New High-Grade Saskatchewan Gold PlayPublished on:5/8/2025
    Thumbnail for A New High-Grade Saskatchewan Gold Play
    Yorkton Equity Group Inc. 🔹 Real Estate
    Record 2024 Results: Positive Outlook Fueled by Rent Growth & Cap Rate CompressionPublished on:5/5/2025
    Thumbnail for Record 2024 Results: Positive Outlook Fueled by Rent Growth & Cap Rate Compression
    Builders Capital Mortgage Corp. 🔹 Mortgage Finance
    Strengthened Portfolio and Dividend ResiliencePublished on:5/2/2025
    Thumbnail for Strengthened Portfolio and Dividend Resilience